C
CMPX
Compass Therapeutics Inc
0.9930
+0.0096+0.98%After Hours: 1.024 +0.031 +3.10%19:59 10/09 EDT
OPEN/PREV CLOSE0.9932/0.9834
TODAY RANGE0.9779-1.050
VOL3.67M
MARKET CAP178.83M
52 WEEK RANGE0.8294-6.88
AVG VOL (3M)4.16M
% TURNOVER1.74%
TURNOVER--
P/E (TTM)-2.4677
% RANGE7.33%
EPS(TTM)-0.4024
P/E(FORWARD)-2.0020
P/B1.077
BVPS0.9220
DIVIDEND--
P/S891.94
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP141.42M
SHARES OUTSTANDING180.09M
NEXT EARNINGS11/03-11/09
FREE FLOAT142.42M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·10/03 13:01
Newegg, Medpace, Compass, Spyre, MINISO Insider Shake-Up
TipRanks·10/03 02:00
Top Executive Quietly Boosts Stake in Emerging Biotech Player
Benzinga·09/24 14:16
This Yum Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Dow Jones·09/23 17:44
Compass Therapeutics Is Maintained at Buy by Craig-Hallum
Dow Jones·09/23 17:44
Compass Therapeutics Price Target Cut to $8.00/Share From $15.00 by Craig-Hallum
Benzinga·09/23 17:34
Craig-Hallum Maintains Buy on Compass Therapeutics, Lowers Price Target to $8
TipRanks·09/23 16:00
Midday Fly By: McDonald’s lays out new strategy, General Mills reports Q1 beat
Seeking Alpha·09/23 15:03
Compass Therapeutics downgraded at Wedbush as FDA seeks additional trial for lead asset
Seeking Alpha·09/23 14:20
Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity
TipRanks·09/23 13:50
Microsoft upgraded, HubSpot initiated: Wall Street’s top analyst calls
Benzinga·09/23 13:09
This Autoliv Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Dow Jones·09/23 12:57
Compass Therapeutics Is Maintained at Market Outperform by Citizens
Dow Jones·09/23 12:57
Compass Therapeutics Price Target Cut to $4.00/Share From $10.00 by Citizens
TipRanks·09/23 12:55
Compass Therapeutics price target lowered to $8 from $15 at Craig-Hallum
Same Industry
Name/Symbol
Change%
Price